Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Video 1: A 29 Sapien-3 ultra-valve deployment
Added: 1 year ago
Interventional Cardiology 2025;20:e03. View more

Intervention

CV Disease in Special Populations
David Northridge
Research Area(s) / Expertise: Job title: Interventional Cardiologist
Dr David Northridge is an interventional cardiologist based in the United Kingdom. He is widely recognised as a leading expert in the management of paravalvular leaks (PVL) and has established an international reputation for his clinical expertise, education, and procedural leadership in structural heart interventions.Academic HistoryDr Northridge has developed his academic career around… View more
ViV TAVR with Navitor: 30-Day Outcomes in Failed Surgical Bioprostheses
Author(s): Added: 2 weeks ago
Dr Virag Kushwaha (Eastern Heart Clinic, New South Wales, AU) joins us to discuss 30-day outcomes of valve-in-valve transcatheter aortic valve replacement using the Navitor system in patients with failed surgical aortic bioprosthetic valves.As the population of patients with ageing surgical bioprostheses continues to grow, valve-in-valve TAVR has become an increasingly important treatment pathway… View more

Intervention
Research Area(s) / Expertise: Job title: Consultant Interventional Cardiologist
Dr Douglas Muir is a Consultant Interventional Cardiologist at The James Cook University Hospital, Middlesbrough, UK.Dr Muir's interests include coronary intervention (rotational atherectomy and laser atherectomy), aortic valve intervention including transcatheter aortic valve implantation (TAVI) and structural intervention (left atrial appendage closure, paravalvar leak closure, mitraclip). View more
Prof Ignacio Cruz
Research Area(s) / Expertise:
Prof Cruz is a Professor of Medicine at the University of Salamanca, Chief of Interventional Cardiology and Elected President of the Spanish Society of Interventional Cardiology. He is a leading and pioneering interventional cardiologist and the main driver behind the Salamanca-based interventional cardiology meetings. He is also highly involved in the research for structural intervention… View more
Fadi J Sawaya
Research Area(s) / Expertise: Job title: Director of the Structural Heart Program
Dr Fadi J Sawaya isDirector of the Structural Heart Program at theAmerican University of Beirut Medical Center, Beirut, Lebanon. His research interests include transcatheter aortic valve implantation (TAVI), left atrial appendage occlusion (LAAC), paravalvular leak closure (PVL), and the treatment of structural heart diseases. Dr Sawaya is an editorial board member ofInterventional Cardiology:… View more
The Index Valve Matters: Optimal Index TAVI for Patients Lifetime Management
Author(s): Michael Joner Added: 5 months ago
In this interview, Prof Michael Joner (German Heart Centre, Munich, DE) discusses the specific needs and treatment considerations when managing low and intermediate risk TAVI patients. He also highlights the increasing need to consider future interventions when selecting the index valve.Prof Joner details the Navitor TAVI system resheathable design with intra-annular function, large-cell frame… View more

Intervention
Eduardo A Arias
Research Area(s) / Expertise:
Dr Arias is Deputy Head of Interventional Cardiology at the "Dr Ignacio Chavez" National Institute of Cardiology in Mexico City. His research interests include complex percutaneous coronary and structural heart interventions, cardiovascular technological innovation, TAVI, Alcohol Septal ablation, and paravalvular leak closure. He is a member of the national research system and the Mexican Society… View more
Procedural Steps of TMVR Using Dedicated Mitral Devices with Dr Guerrero
Author(s): Mayra Guerrero Added: 7 months ago
Gain essential insights into the pivotal trials and procedural techniques shaping transcatheter mitral valve replacement with Dr Mayra GuerreroThis presentation, part of Women As One's comprehensive Structural Interventions track, provides timely analysis of the landmark SUMMIT and ENCIRCLE trials that are defining the future of dedicated mitral devices.Drawing from clinical trial data showing… View more

Intervention
ACC 2025: EVOLUT Low Risk 5Y Outcomes
Author(s): Michael J Reardon Added: 1 year ago
ACC 2025 - EVOLUT Low-Risk findings show the Medtronic TAVR system is a safe and effective treatment for aortic stenosis vs surgical valves at five years.Dr Michael Reardon (Houston Methodist, Texas, US) joins us onsite at ACC to discuss the EVOLUT Low Risk trial (NCT02701283; Medtronic Cardiovascular), investigating the safety and effectiveness of the Medtronic TAVR system compared to surgical… View more

Intervention